Vimarsana
Biggest News Aggregation in the World

Page 45 - Development Partnership News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Development Partnership. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Development Partnership Today - Breaking & Trending Today

Oral Zoliflodacin Noninferior to Standard of Care for Uncomplicated Gonorrhea - Vimarsana News

Oral Zoliflodacin Noninferior to Standard of Care for Uncomplicated Gonorrhea

Treatment with oral zoliflodacin was found to be noninferior to ceftriaxone and oral azithromycin for the treatment of gonorrhea infection.

Source: empr.com
New antibiotic shows promise for drug-resistant gonorrhea – NBC Los Angeles - Vimarsana News

New antibiotic shows promise for drug-resistant gonorrhea – NBC Los Angeles

Gonorrhea, the second most common STI in the U.S., has developed resistance to all antibiotics used to treat it, except for one last recommended therapy.

New antibiotic shows promise for drug-resistant gonorrhea – NBC10 Philadelphia - Vimarsana News

New antibiotic shows promise for drug-resistant gonorrhea – NBC10 Philadelphia

Gonorrhea, the second most common STI in the U.S., has developed resistance to all antibiotics used to treat it, except for one last recommended therapy.

New antibiotic shows promise for drug-resistant gonorrhea – NBC 5 Dallas-Fort Worth - Vimarsana News

New antibiotic shows promise for drug-resistant gonorrhea – NBC 5 Dallas-Fort Worth

Gonorrhea, the second most common STI in the U.S., has developed resistance to all antibiotics used to treat it, except for one last recommended therapy.

Source: nbcdfw.com
New antibiotic shows promise for drug-resistant gonorrhea – NBC 6 South Florida - Vimarsana News

New antibiotic shows promise for drug-resistant gonorrhea – NBC 6 South Florida

Gonorrhea, the second most common STI in the U.S., has developed resistance to all antibiotics used to treat it, except for one last recommended therapy.